Humalog Kwikpen Mix 25 Eli Lilly

£241.00

Humalog KwikPen Mix 25 is a rapid-acting insulin formulation developed by Eli Lilly for laboratory investigation of glucose metabolism and insulin physiology. This mixed insulin preparation contains both rapid and intermediate-acting insulin components for research applications.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Humalog Kwikpen Mix 25 Eli Lilly
Humalog Kwikpen Mix 25 Eli Lilly
£241.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Understanding Humalog KwikPen Mix 25

Humalog KwikPen Mix 25 is a rapid-acting insulin formulation developed by pharmaceutical manufacturer Eli Lilly for research purposes. This mixed insulin preparation combines insulin lispro with protamine-bound insulin lispro suspension, creating a dual-phase insulin system that researchers can study for its pharmacokinetic and pharmacodynamic properties. The KwikPen delivery system represents Eli Lilly’s pre-filled pen technology designed for consistent and accurate research dosing protocols. Scientists investigating Stroid UK Shop often utilise this formulation to examine insulin action patterns and glucose homeostasis mechanisms.

Laboratory Research Applications

Research teams investigate this insulin formulation across multiple study domains including endocrine physiology, diabetes pathophysiology, and metabolic syndrome models. The mixed insulin profile allows researchers to examine both immediate and sustained insulin responses within controlled experimental conditions. Laboratory studies frequently analyse this compound’s effects on glucose uptake mechanisms, hepatic glucose production, and peripheral insulin sensitivity markers. Advanced research protocols incorporate this insulin preparation when investigating cellular signalling pathways, GLUT4 translocation studies, and pancreatic beta-cell function assessments. Scientists working with insulin research compounds utilise this formulation for comparative pharmacological studies and metabolic pathway investigations. Research applications extend to examining insulin resistance mechanisms, studying incretin hormone interactions, and evaluating glucose clamp methodology refinements in laboratory settings.

Product Specifications

Humalog KwikPen Mix 25 Research Specifications
Parameter Specification
Manufacturer Eli Lilly
Active Components 25% Insulin Lispro, 75% Insulin Lispro Protamine Suspension
Delivery System KwikPen Pre-filled Device
Research Grade Pharmaceutical Standard
Storage Temperature 2-8°C (Refrigerated)
Documentation Research Certificate Available

Researchers studying selective androgen receptor modulators often incorporate insulin studies to understand metabolic interactions, while those investigating peptide hormones examine insulin’s role in growth factor signalling cascades.

Research Compliance Statement

Humalog KwikPen Mix 25 is supplied exclusively for in-vitro laboratory research and analytical testing purposes only. This insulin formulation is not intended for human consumption, therapeutic applications, or any clinical use. Research institutions must ensure proper storage conditions, handling protocols, and disposal procedures according to institutional biosafety guidelines. All studies should be conducted under appropriate ethical approval and laboratory supervision with qualified research personnel.

Related